Health News Archive - May 17, 2009
Positive data from subgroup analysis presented at 19th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) meeting in Helsinki, Finland SAN DIEGO, May 17 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc.
Survey says corporate wellness programs, walking offer ways to keep health on track DALLAS, May 17 /PRNewswire-USNewswire/ -- Yet another negative result of the bad economy: Americans are cutting back on healthy activities such as eating fresh foods and exercising regularly. In a national omnibus survey of 1,000 people conducted in March 2009 by the American Heart Association: 57 percent said the economy has affected their ability to take care of their health.
Asserts Rights to Phase 2 Anti-Cancer Compound Discovered During Joint Research EMERYVILLE, Calif., May 17 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc.
- Change in Forced Vital Capacity is among strongest predictors of one-year mortality - SAN DIEGO, May 17 /PRNewswire-FirstCall/ -- InterMune, Inc.
--Gene Transfer Technology May Lead to an HIV Vaccine-- PHILADELPHIA, May 17 /PRNewswire-USNewswire/ -- A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers.
Japan confirmed 20 new cases of swine flu on Sunday, while senior health officials gathered in Geneva to discuss how to contain the virus.
Reykjavik, ICELAND, May 17 /PRNewswire-FirstCall/ -- In a paper published today in the online edition of Nature Genetics, scientists from deCODE genetics (Nasdaq:DCGN) and academic colleagues from Iceland, Denmark and the Netherlands present the discovery of single letter variations in the sequence of the human genome (SNPs) that influence the age of girls at menarche, the first menstrual period.
ATLANTA, May 17 /PRNewswire/ -- Hai Kang Life Corporation Limited (HKLife) announces further developments of its patented field-assisted LOAC (Lab-on-a-Chip) system, EFADchip technology at the BIO 2009 International Convention, the Global Event for Biotechnology held in Atlanta, through 18-21 May 2009.
CARLSBAD, Calif., May 17 /PRNewswire/ -- Essentialis Inc, a clinical stage pharmaceutical company, announced today that it met its primary endpoint of statistically significant triglyceride reduction in a 90-patient Phase 2b trial of DCCR in dyslipidemic patients.
AVAC Report Assesses Progress in AIDS Vaccine, Microbicide and PrEP Research and Calls for Urgent Coordination and Leadership in Advance of Upcoming Results NEW YORK, May 18 /PRNewswire-USNewswire/ -- "It's an exciting time in HIV prevention research.